Evidence map›Paper›PMID 39509324›Full record

ArticleJCI insight2024

Gpnmb and Spp1 mark a conserved macrophage injury response masking fibrosis-specific programming in the lung.

Emily M King, Yifan Zhao, Camille M Moore, Benjamin Steinhart, Kelsey C Anderson, Brian Vestal, Peter K Moore, Shannon A McManus, Christopher M Evans, Kara J Mould and 3 more

Abstract read
In one paragraph

Article in JCI insight, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. A population-scale atlas of blood and tissue in lupus nephritis.bioRxiv : the preprint server for biology · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Monocyte-Derived LGMNResearch (Washington, D.C.) · 2026
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Emily M KingMedical Scientist Training Program, University of Colorado School of Medicine, Aurora, Colorado, USA.
Yifan ZhaoCenter for Genes, Environment, and Health, and.
Camille M MooreCenter for Genes, Environment, and Health, and.
Benjamin SteinhartDepartment of Medicine, National Jewish Health, Denver, Colorado, USA.
Kelsey C AndersonCenter for Genes, Environment, and Health, and.
Brian VestalCenter for Genes, Environment, and Health, and.
Peter K MooreDepartment of Medicine, National Jewish Health, Denver, Colorado, USA.
Shannon A McManusDepartment of Medicine, National Jewish Health, Denver, Colorado, USA.
Christopher M EvansDepartment of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
Kara J MouldDepartment of Medicine, National Jewish Health, Denver, Colorado, USA.
Elizabeth F RedenteDepartment of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
Alexandra L McCubbreyDepartment of Medicine, National Jewish Health, Denver, Colorado, USA.
William J JanssenDepartment of Medicine, National Jewish Health, Denver, Colorado, USA.

Funding

Role of Mucin in Lung Homeostasis and PathophysiologyR01HL080396 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Christopher M Evans · 2009 to 2026
$8.6M
Lung Macrophage Programming in Acute Lung InjuryR35HL140039 · NHLBI · NATIONAL JEWISH HEALTH · PI JANSSEN, WILLIAM · 2018 to 2024
$6.4M
Mechanisms of lung macrophage programming by MUC5B during health and diseaseR01HL130938 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI EVANS, CHRISTOPHER M · 2016 to 2025
$5.2M
Roles for interstitial and airspace macrophages in resolution of pulmonary inflammationR01HL149741 · NHLBI · NATIONAL JEWISH HEALTH · PI HENSON, PETER M, REDENTE, ELIZABETH FRANCES · 2020 to 2023
$3.0M
Macrophage Metabolism After Target Cell Ingestion Regulates Anti-Inflammatory ReprogrammingR00HL141658 · NHLBI · NATIONAL JEWISH HEALTH · PI MCCUBBREY, ALEXANDRA LEIGH · 2020 to 2022
$747k
NHLBI NIH HHS R00 HL141658NHLBI NIH HHS R01 HL080396NHLBI NIH HHS R01 HL130938NHLBI NIH HHS R01 HL149741NHLBI NIH HHS R35 HL140039
6 · The paper itself

Abstract

Macrophages are required for healthy repair of the lungs following injury, but they are also implicated in driving dysregulated repair with fibrosis. How these 2 distinct outcomes of lung injury are mediated by different macrophage subsets is unknown. To assess this, single-cell RNA-Seq was performed on lung macrophages isolated from mice treated with LPS or bleomycin. Macrophages were categorized based on anatomic location (airspace versus interstitium), developmental origin (embryonic versus recruited monocyte derived), time after inflammatory challenge, and injury model. Analysis of the integrated dataset revealed that macrophage subset clustering was driven by macrophage origin and tissue compartment rather than injury model. Gpnmb-expressing recruited macrophages that were enriched for genes typically associated with fibrosis were present in both injury models. Analogous GPNMB-expressing macrophages were identified in datasets from both fibrotic and nonfibrotic lung disease in humans. We conclude that this subset represents a conserved response to tissue injury and is not sufficient to drive fibrosis. Beyond this conserved response, we identified that recruited macrophages failed to gain resident-like programming during fibrotic repair. Overall, fibrotic versus nonfibrotic tissue repair is dictated by dynamic shifts in macrophage subset programming and persistence of recruited macrophages.

Indexed as

LungLung InjuryMembrane GlycoproteinsPulmonary FibrosisAnimalsBleomycinDisease Models, AnimalEye ProteinsFibrosisHumansLipopolysaccharidesMacrophagesMacrophages, AlveolarMaleMiceMice, Inbred C57BLBleomycinEye ProteinsGpnmb protein, mouseLipopolysaccharidesMembrane GlycoproteinsFibrosisImmunologyInflammationMacrophages

Identifiers

PMID39509324
PMCPMC11665561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.